| Trial ID: | L4850 |
| Source ID: | NCT00898950
|
| Associated Drug: |
Aspirin
|
| Title: |
Effects of Different Doses of Aspirin on Pathophysiological Markers in Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Type 2
|
| Interventions: |
DRUG: Aspirin|DRUG: Aspirin|DRUG: Aspirin|OTHER: placebo tablet
|
| Outcome Measures: |
Primary: Change in markers of oxidative stress, endothelial function, glycaemic control, and insulin resistance, 2 weeks | Secondary: Change in inflammatory markers, 2 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Portsmouth
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2004-08
|
| Completion Date: |
2006-07
|
| Results First Posted: |
|
| Last Update Posted: |
2009-05-12
|
| Locations: |
School of Pharmacy and Biomedical Sciences, University of Posrtmouth, Portsmouth, Hampshire, PO1 2DT, United Kingdom|Diabetes Centre, Queen Alexandra Hospital, Portsmouth Hospitals NHS Trust, Portsmouth, Hampshire, PO6 3LY, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00898950
|
